(Q39946671)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4607450%20AND%20SRC:MED&resulttype=core&format=json

30 September 2019

review article

1 reference

title

Drug selection and dosage in renal insufficiency (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4607450%20AND%20SRC:MED&resulttype=core&format=json

30 September 2019

Drug Selection and Dosage in Renal Insufficiency (English)

1 reference

https://api.crossref.org/works/10.1007/978-3-642-65746-7_3

12 February 2023

author name string

J. Fabre

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4607450

12 February 2023

I. Ohr

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4607450

12 February 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=4607450

12 February 2023

publication date

1 January 1974

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4607450%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

30 September 2019

http://link.springer.com/content/pdf/10.1007/978-3-642-65746-7_3.pdf

file format

Portable Document Format

1 reference

https://api.crossref.org/works/10.1007/978-3-642-65746-7_3

Ergebnisse der inneren Medizin und Kinderheilkunde

12 February 2023

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4607450%20AND%20SRC:MED&resulttype=core&format=json

30 September 2019

volume

34

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4607450%20AND%20SRC:MED&resulttype=core&format=json

30 September 2019

issue

0

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4607450%20AND%20SRC:MED&resulttype=core&format=json

30 September 2019

page(s)

45-104

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4607450%20AND%20SRC:MED&resulttype=core&format=json

Acute renal failure and pigmentation due to phenazopyridine (Pyridium).

30 September 2019

cites work

1

1 reference

https://api.crossref.org/works/10.1007/978-3-642-65746-7_3

Metabolism of 35S-labelled antithyroid drugs in man.

12 February 2023

2

1 reference

https://api.crossref.org/works/10.1007/978-3-642-65746-7_3

THE USE OF POTENTIALLY NEPHROTOXIC ANTIBIOTICS IN THE TREATMENT OF GRAM-NEGATIVE INFECTIONS IN UREMIC PATIENTS.

12 February 2023

6

1 reference

https://api.crossref.org/works/10.1007/978-3-642-65746-7_3

The metabolic fate of vitamin D3-3H in chronic renal failure

12 February 2023

7

1 reference

https://api.crossref.org/works/10.1007/978-3-642-65746-7_3

The metabolism of azathioprine in renal failure

12 February 2023

10

1 reference

https://api.crossref.org/works/10.1007/978-3-642-65746-7_3

Pharmacokinetics of glipizide in man: Influence of renal insufficiency

12 February 2023

12

1 reference

https://api.crossref.org/works/10.1007/978-3-642-65746-7_3

THE FATE OF BIGUANIDES IN MAN

12 February 2023

15

1 reference

https://api.crossref.org/works/10.1007/978-3-642-65746-7_3

A Practical Guide to Drug Usage in Adult Patients With Impaired Renal Function

12 February 2023

16

1 reference

https://api.crossref.org/works/10.1007/978-3-642-65746-7_3

Relationship of the excretion of tritiated digoxin to renal function

12 February 2023

21

1 reference

https://api.crossref.org/works/10.1007/978-3-642-65746-7_3

12 February 2023

22

20

393

JR Boissier

1965

1 reference

https://api.crossref.org/works/10.1007/978-3-642-65746-7_3

Cardiac glycoside therapy in patients with renal failure

12 February 2023

25

1 reference

https://api.crossref.org/works/10.1007/978-3-642-65746-7_3

Complications during clofibrate treatment of nephrotic-syndrome hyperlipoproteinaemia

12 February 2023

28

1 reference

https://api.crossref.org/works/10.1007/978-3-642-65746-7_3

NEUROCHEMICAL TRANSDUCER SYSTEMS

12 February 2023

31

1 reference

https://api.crossref.org/works/10.1007/978-3-642-65746-7_3

12 February 2023

33

16

393

G Brouet

1961

1 reference

https://api.crossref.org/works/10.1007/978-3-642-65746-7_3

Hypokalaemia, Metabolic Alkalosis, and Hypernatraemia due to "Massive" Sodium Penicillin Therapy

12 February 2023

36

1 reference

https://api.crossref.org/works/10.1007/978-3-642-65746-7_3

EFFECT OF UREMIA ON METHICILLIN AND OXACILLIN BLOOD LEVELS

12 February 2023

38

1 reference

https://api.crossref.org/works/10.1007/978-3-642-65746-7_3

The urinary excretion and biologic decay periods of radiomercury labeling a mercurial diuretic in normal and diseased man

12 February 2023

40

1 reference

https://api.crossref.org/works/10.1007/978-3-642-65746-7_3

ON PHARMACOKINETICS OF SULFONAMIDES UNDER PATHOLOGICAL CONDITIONS

12 February 2023

45

1 reference

https://api.crossref.org/works/10.1007/978-3-642-65746-7_3

Accumulation of barbitone in patients on regular haemodialysis

12 February 2023

47

1 reference

https://api.crossref.org/works/10.1007/978-3-642-65746-7_3

Toxic effect of streptomycin upon balance and hearing.

12 February 2023

50

1 reference

https://api.crossref.org/works/10.1007/978-3-642-65746-7_3

Gentamicin therapy in renal failure: a nomogram for dosage.

12 February 2023

51

1 reference

https://api.crossref.org/works/10.1007/978-3-642-65746-7_3

Nonketoacidotic Hyperglycemia and Coma During Intravenous Diazoxide Therapy in Uremia

12 February 2023

52

1 reference

https://api.crossref.org/works/10.1007/978-3-642-65746-7_3

THE PHYSIOLOGIC DISPOSITION OF 5-FLUOROURACIL AND 5-FLUORO-2'-DEOXYURIDINE IN MAN

12 February 2023

56

1 reference

https://api.crossref.org/works/10.1007/978-3-642-65746-7_3

Carbohydrate metabolism in uremia: blood glucose response to sulfonylurea

12 February 2023

57

1 reference

https://api.crossref.org/works/10.1007/978-3-642-65746-7_3

The Metabolism and Elimination of d-Tubocurarine-H3

12 February 2023

58

1 reference

https://api.crossref.org/works/10.1007/978-3-642-65746-7_3

Ethacrynic Acid Effect on the Composition of Cochlear Fluids

12 February 2023

59

1 reference

https://api.crossref.org/works/10.1007/978-3-642-65746-7_3

[The effect of guanethidine on hypertension and renal function in the therapy of hospitalized and ambulant patients.]

12 February 2023

61

1 reference

https://api.crossref.org/works/10.1007/978-3-642-65746-7_3

Nephrotoxicity Associated with Methoxyflurane Anesthesia

12 February 2023

62

1 reference

https://api.crossref.org/works/10.1007/978-3-642-65746-7_3

Colistin sulphomethate sodium administration in the presence of severe renal failure and during haemodialysis and peritoneal dialysis.

12 February 2023

63

1 reference

https://api.crossref.org/works/10.1007/978-3-642-65746-7_3

The clinical pharmacology of digitalis glycosides: a review

12 February 2023

75

1 reference

https://api.crossref.org/works/10.1007/978-3-642-65746-7_3

Studies with tritiated digoxin in anephric human subjects

12 February 2023

76

1 reference

https://api.crossref.org/works/10.1007/978-3-642-65746-7_3

STUDIES WITH TRITIATED DIGOXIN IN RENAL FAILURE

12 February 2023

77

1 reference

https://api.crossref.org/works/10.1007/978-3-642-65746-7_3

Methyldopa in hypertension

12 February 2023

78

1 reference

https://api.crossref.org/works/10.1007/978-3-642-65746-7_3

Clinical and pharmacological studies with guanethidine in the treatment of hypertension

12 February 2023

79

1 reference

https://api.crossref.org/works/10.1007/978-3-642-65746-7_3

The metabolic fate of amphetamine in man and other species

12 February 2023

81

1 reference

https://api.crossref.org/works/10.1007/978-3-642-65746-7_3

Carbenicillin administration in patients with severe renal failure.

12 February 2023

86

1 reference

https://api.crossref.org/works/10.1007/978-3-642-65746-7_3

Streptomycin poisoning in renal failure; an indication for treatment with an artificial kidney.

12 February 2023

87

1 reference

https://api.crossref.org/works/10.1007/978-3-642-65746-7_3

Renal clearance of oxipurinol, the chief metabolite of allopurinol

12 February 2023

89

1 reference

https://api.crossref.org/works/10.1007/978-3-642-65746-7_3

Nitrogen and electrolyte metabolism and hepatic function and histology in patients receiving tetracyline

12 February 2023

100

1 reference

https://api.crossref.org/works/10.1007/978-3-642-65746-7_3

Metabolism of L-thyroxine and L-triiodothyronine in the absence of the liver

12 February 2023

101

1 reference

https://api.crossref.org/works/10.1007/978-3-642-65746-7_3

Renal tubular necrosis due to nephrotoxicity of organic mercurial diuretics

12 February 2023

103

1 reference

https://api.crossref.org/works/10.1007/978-3-642-65746-7_3

The blood-cerebrospinal fluid barrier in uremia.

12 February 2023

104

1 reference

https://api.crossref.org/works/10.1007/978-3-642-65746-7_3

[Studies on kidney function during anesthesia and surgery]

12 February 2023

105

1 reference

https://api.crossref.org/works/10.1007/978-3-642-65746-7_3

Quinidine Excretion in Aciduria and Alkaluria

12 February 2023

108

1 reference

https://api.crossref.org/works/10.1007/978-3-642-65746-7_3

Dose of gentamicin in patients with normal renal function and renal impairment.

12 February 2023

110

1 reference

https://api.crossref.org/works/10.1007/978-3-642-65746-7_3

Urinary excretion of nalidixic acid, sulfamethizole and nitrofurantoin in patients with reduced renal function

12 February 2023

114

1 reference

https://api.crossref.org/works/10.1007/978-3-642-65746-7_3

The effects of renal impairment, peritoneal dialysis, and hemodialysis on serum sodium colistimethate levels

12 February 2023

116

1 reference

https://api.crossref.org/works/10.1007/978-3-642-65746-7_3

Everest MS: Measurement of digoxin in plasma and its use in diagnosis of digoxin intoxication.

12 February 2023

117

1 reference

https://api.crossref.org/works/10.1007/978-3-642-65746-7_3

Removal and absorption of antibiotics in patients with renal failure undergoing peritoneal dialysis. Tetracycline, chloramphenicol, kanamycin, and colistimethate

12 February 2023

118

1 reference

https://api.crossref.org/works/10.1007/978-3-642-65746-7_3

Abuse of phenacetin and nephropathy

12 February 2023

119

1 reference

https://api.crossref.org/works/10.1007/978-3-642-65746-7_3

Cerebral circulation and metabolism in uremia

12 February 2023

123

1 reference

https://api.crossref.org/works/10.1007/978-3-642-65746-7_3

Nephrotoxicity Associated With the Use of Cephaloridine

12 February 2023

124

1 reference

https://api.crossref.org/works/10.1007/978-3-642-65746-7_3

Pharmacodynamics of Carbenicillin in Hepatic and Renal Failure

12 February 2023

125

1 reference

https://api.crossref.org/works/10.1007/978-3-642-65746-7_3

A quantitative study of chlorpromazine and its sulfoxides in the urine of psychotic patients

12 February 2023

127

1 reference

https://api.crossref.org/works/10.1007/978-3-642-65746-7_3

An Improved Method of Digoxin Therapy

12 February 2023

128

1 reference

https://api.crossref.org/works/10.1007/978-3-642-65746-7_3

An Improved Method of Digitoxin Therapy

12 February 2023

129

1 reference

https://api.crossref.org/works/10.1007/978-3-642-65746-7_3

Deterioration in renal function in association with co-trimoxazole therapy

12 February 2023

133

1 reference

https://api.crossref.org/works/10.1007/978-3-642-65746-7_3

The metabolism of glutethimide (Doriden®)

12 February 2023

136

1 reference

https://api.crossref.org/works/10.1007/978-3-642-65746-7_3

Clinical pharmacology of chlorothiazide compounds

12 February 2023

137

1 reference

https://api.crossref.org/works/10.1007/978-3-642-65746-7_3

Adverse effects of sodium colistimethate. Manifestations and specific reaction rates during 317 courses of therapy

12 February 2023

140

1 reference

https://api.crossref.org/works/10.1007/978-3-642-65746-7_3

Blood level kinetics and renal clearance of H3 peruvosid

12 February 2023

145

1 reference

https://api.crossref.org/works/10.1007/978-3-642-65746-7_3

A guide to use of antibiotics in patients with renal disease. A table of recommended doses and factors governing serum levels

12 February 2023

149

1 reference

https://api.crossref.org/works/10.1007/978-3-642-65746-7_3

Oral Cephalexin and Ampicillin: Antimicrobial Activity, Recovery in Urine, and Persistence in Blood of Uremic Patients

12 February 2023

152

1 reference

https://api.crossref.org/works/10.1007/978-3-642-65746-7_3

Persistence of antibiotics in blood of patients with acute renal failure. III. Penicillin, streptomycin, erythromycin and kanamycin

12 February 2023

153

1 reference

https://api.crossref.org/works/10.1007/978-3-642-65746-7_3

Persistence of antibiotics in blood of patients with acute renal failure. II. Chloramphenicol and its metabolic products in the blood of patients with severe renal disease or hepatic cirrhosis

12 February 2023

155

1 reference

https://api.crossref.org/works/10.1007/978-3-642-65746-7_3

Persistence of antibiotics in blood of patients with acute renal failure. I. Tetracycline and chlortetracycline

12 February 2023

156

1 reference

https://api.crossref.org/works/10.1007/978-3-642-65746-7_3

Methoxyflurane, Tetracycline, and Renal Failure

12 February 2023

157

1 reference

https://api.crossref.org/works/10.1007/978-3-642-65746-7_3

Relation between the metabolic processes and mode of renal excretion of sulfonamides

12 February 2023

160

1 reference

https://api.crossref.org/works/10.1007/978-3-642-65746-7_3

Correlation of urinary output with serum and spinal fluid mannitol levels in normal and azotemic patients

12 February 2023

161

1 reference

https://api.crossref.org/works/10.1007/978-3-642-65746-7_3

ULCERATIVE-OBSTRUCTIVE LESIONS OF THE SMALL INTESTINE

12 February 2023

165

1 reference

https://api.crossref.org/works/10.1007/978-3-642-65746-7_3

Concentration of chloramphenicol in the urine and blood in relation to renal function

12 February 2023

167

1 reference

https://api.crossref.org/works/10.1007/978-3-642-65746-7_3

Effect of renal function on excretion of sulfadimetine given in small doses for urinary infection

12 February 2023

172

1 reference

https://api.crossref.org/works/10.1007/978-3-642-65746-7_3

Ototoxic Drugs and Poor Renal Function

12 February 2023

185

1 reference

https://api.crossref.org/works/10.1007/978-3-642-65746-7_3

Computer-assisted prescribing of kanamycin for patients with renal insufficiency

12 February 2023

186

1 reference

https://api.crossref.org/works/10.1007/978-3-642-65746-7_3

Nomogram for kanamycin dosage

12 February 2023

187

1 reference

https://api.crossref.org/works/10.1007/978-3-642-65746-7_3

Gentamicin dosages for renal insufficiency. Adjustments based on endogenous creatinine clearance and serum creatinine concentration

12 February 2023

190

1 reference

https://api.crossref.org/works/10.1007/978-3-642-65746-7_3

Amphotericin B toxicity. A follow-up report of 53 patients

12 February 2023

197

1 reference

https://api.crossref.org/works/10.1007/978-3-642-65746-7_3

Succinylcholine-induced Hyperkalemia in Patients with Renal Failure?

12 February 2023

198

1 reference

https://api.crossref.org/works/10.1007/978-3-642-65746-7_3

THE CIRCUMFERENTIAL SMALL-BOWEL ULCER: CLINICAL ASPECTS IN 17 PATIENTS

12 February 2023

201

1 reference

https://api.crossref.org/works/10.1007/978-3-642-65746-7_3

Uraemic accentuation of chlorpromazine pigmentation

12 February 2023

203

1 reference

https://api.crossref.org/works/10.1007/978-3-642-65746-7_3

The influence of renal disease on the insulin I131 disappearance curve in man

12 February 2023

205

1 reference

https://api.crossref.org/works/10.1007/978-3-642-65746-7_3

Abnormal pharmacokinetics of phenytoin in a patient with uraemia

12 February 2023

206

1 reference

https://api.crossref.org/works/10.1007/978-3-642-65746-7_3

Pulmonary tuberculosis in patient on intermittent haemodialysis.

12 February 2023

207

1 reference

https://api.crossref.org/works/10.1007/978-3-642-65746-7_3

Clonidine: a new antihypertensive agent

12 February 2023

211

1 reference

https://api.crossref.org/works/10.1007/978-3-642-65746-7_3

The relationship between kanamycin pharmacokinetics: Distribution and renal function

12 February 2023

212

1 reference

https://api.crossref.org/works/10.1007/978-3-642-65746-7_3

Renal function during general anesthesia and operation.

12 February 2023

215

1 reference

https://api.crossref.org/works/10.1007/978-3-642-65746-7_3

THE ABSORPTION, EXCRETION, AND METABOLIC FATE OF ETHAMBUTOL IN MAN

12 February 2023

218

1 reference

https://api.crossref.org/works/10.1007/978-3-642-65746-7_3

Transient and permanent deafness following treatment with ethacrynic acid in renal failure

12 February 2023

223

1 reference

https://api.crossref.org/works/10.1007/978-3-642-65746-7_3

Cadaveric renal transplantation. An analysis of 65 cases

12 February 2023

226

1 reference

https://api.crossref.org/works/10.1007/978-3-642-65746-7_3

Use of Diazoxide in Hypertension with Renal Failure

12 February 2023

227

1 reference

https://api.crossref.org/works/10.1007/978-3-642-65746-7_3

Anticoagulants in the Treatment of Renal Disease

12 February 2023

228

1 reference

https://api.crossref.org/works/10.1007/978-3-642-65746-7_3

Changes in serum potassium following suxamethonium in the uraemic rat

12 February 2023

229

1 reference

https://api.crossref.org/works/10.1007/978-3-642-65746-7_3

EFFECTS OF ACETYLSALICYLIC ACID, PHENACETIN, PARACETAMOL, AND CAFFEINE ON RENAL TUBULAR EPITHELIUM

12 February 2023

230

1 reference

https://api.crossref.org/works/10.1007/978-3-642-65746-7_3

The metabolism of phenacetin in patients with renal disease

12 February 2023

231

1 reference

https://api.crossref.org/works/10.1007/978-3-642-65746-7_3

Dose-dependent change in the pattern of phenacetin metabolism in man and its possible significance in analgesic nephropathy

12 February 2023

232

1 reference

https://api.crossref.org/works/10.1007/978-3-642-65746-7_3

During-induced lactation in uremia

12 February 2023

233

1 reference

https://api.crossref.org/works/10.1007/978-3-642-65746-7_3

Studies on the metabolism of guanethidine in hypertensive patients

12 February 2023

235

1 reference

https://api.crossref.org/works/10.1007/978-3-642-65746-7_3

Rate of drug metabolism in obese volunteers before and during starvation and in azotemic patients

12 February 2023

238

1 reference

https://api.crossref.org/works/10.1007/978-3-642-65746-7_3

Blood levels, excretion and dosage of N-pyrrolidino-methyl-tetracycline (PMT, Reverin) in kidney patients

12 February 2023

241

1 reference

https://api.crossref.org/works/10.1007/978-3-642-65746-7_3

Effects of reduced glomerular filtration rate on responsiveness to chlorothiazide and mercurial diuretics

12 February 2023

242

1 reference

https://api.crossref.org/works/10.1007/978-3-642-65746-7_3

Pharmacology of Gentamicin in Man

12 February 2023

254

1 reference

https://api.crossref.org/works/10.1007/978-3-642-65746-7_3

Excretion of piperazine salts in urine.

12 February 2023

256

1 reference

https://api.crossref.org/works/10.1007/978-3-642-65746-7_3

Pharmacokinetics of accumulation.

12 February 2023

258

1 reference

https://api.crossref.org/works/10.1007/978-3-642-65746-7_3

The clinical importance of hyperkalaemia following suxamethonium administration

12 February 2023

259

1 reference

https://api.crossref.org/works/10.1007/978-3-642-65746-7_3

Use of bishydroxycoumarin (dicumarol) in the presence of impaired renal function

12 February 2023

261

1 reference

https://api.crossref.org/works/10.1007/978-3-642-65746-7_3

Effects of uremia on cerebral blood flow and metabolism.

12 February 2023

262

1 reference

https://api.crossref.org/works/10.1007/978-3-642-65746-7_3

INCREASE OF DIGITALIS TOXICITY CAUSED BY RENAL INSUFFICIENCY

12 February 2023

264

1 reference

https://api.crossref.org/works/10.1007/978-3-642-65746-7_3

HEMOSIDEROSIS VERSUS HEMOCHROMATOSIS: REFRACTORY ANEMIA, HEPATIC DYSFUNCTION, DIABETES AND INCREASED TISSUE IRON DEPOSITS

12 February 2023

265

1 reference

https://api.crossref.org/works/10.1007/978-3-642-65746-7_3

Plasma propranolol levels in adults With observations in four children

12 February 2023

271

1 reference

https://api.crossref.org/works/10.1007/978-3-642-65746-7_3

Renal disease and the metabolic effects of tetracycline

12 February 2023

272

1 reference

https://api.crossref.org/works/10.1007/978-3-642-65746-7_3

Persistent excretion of pyrimethamine following oral administration

12 February 2023

274

1 reference

https://api.crossref.org/works/10.1007/978-3-642-65746-7_3

Some aspects of anaesthesia for renal homotransplantation

12 February 2023

281

1 reference

https://api.crossref.org/works/10.1007/978-3-642-65746-7_3

Effect of deficiency of renal tissue with or without resulting hypertension on the electrolyte composition of brain and skeletal muscle.

12 February 2023

285

1 reference

https://api.crossref.org/works/10.1007/978-3-642-65746-7_3

The excretion of atropine and allied alkaloids in urine

12 February 2023

286

1 reference

https://api.crossref.org/works/10.1007/978-3-642-65746-7_3

12 February 2023

289

23

511

J Traeger

1968

1 reference

https://api.crossref.org/works/10.1007/978-3-642-65746-7_3

DISAPPEARANCE RATE OF TOLBUTAMIDE IN NORMAL SUBJECTS AND IN DIABETES MELLITUS, LIVER CIRRHOSIS, AND RENAL DISEASE

12 February 2023

290

1 reference

https://api.crossref.org/works/10.1007/978-3-642-65746-7_3

RENAL TUBULAR MECHANISMS FOR EXCRETION OF ORGANIC ACIDS AND BASES.

12 February 2023

297

1 reference

https://api.crossref.org/works/10.1007/978-3-642-65746-7_3

The metabolism of amiloride hydrochloride in man

12 February 2023

299

1 reference

https://api.crossref.org/works/10.1007/978-3-642-65746-7_3

Absorption and excretion of viomycin in humans

12 February 2023

300

1 reference

https://api.crossref.org/works/10.1007/978-3-642-65746-7_3

Renal Insufficiency Associated with Gentamicin Therapy

12 February 2023

302

1 reference

https://api.crossref.org/works/10.1007/978-3-642-65746-7_3

Renal clearance of sodium sulphadimidine in normal and uraemic subjects

12 February 2023

303

1 reference

https://api.crossref.org/works/10.1007/978-3-642-65746-7_3

Renal transplantation in man. Experience in 35 cases.

12 February 2023

305

1 reference

https://api.crossref.org/works/10.1007/978-3-642-65746-7_3

The anaesthetist looks at tissue transplantation: three years' experience with kidney transplants.

12 February 2023

308

1 reference

https://api.crossref.org/works/10.1007/978-3-642-65746-7_3

Mechanism of the renal excretion of methonium compounds.

12 February 2023

309

1 reference

https://api.crossref.org/works/10.1007/978-3-642-65746-7_3

Toxicity of polymyxin B. II. Human studies with particular reference to evaluation of renal function

12 February 2023

310

1 reference

https://api.crossref.org/works/10.1007/978-3-642-65746-7_3

12 February 2023

Identifiers

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=4607450

12 February 2023

1 reference